Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia

5-Hydroxytryptamine type 2 antagonists are used to treat symptomatic peripheral arterial disease. However, it remains unknown as to whether the administration of sarpogrelate, a 5-hydroxytryptamine type 2 antagonist, improves the prognosis after endovascular therapy for critical limb ischemia (CLI)....

Descripción completa

Detalles Bibliográficos
Autores principales: Takahara, Mitsuyoshi, Kaneto, Hideaki, Katakami, Naoto, Iida, Osamu, Matsuoka, Taka-aki, Shimomura, Iichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2013
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085500/
https://www.ncbi.nlm.nih.gov/pubmed/23494607
http://dx.doi.org/10.1007/s00380-013-0334-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085500/
https://www.ncbi.nlm.nih.gov/pubmed/23494607
http://dx.doi.org/10.1007/s00380-013-0334-1

Ejemplares similares